Medicines For Europe’s Leader Marks A Decade Of Change

Towards the end of 2013, Adrian van den Hoven took over as director general of what was then the European Generic and Biosimilar medicines Association (EGA). Now, a decade on, he is still at the helm of the organization now known as Medicines for Europe.

In an exclusive in-depth three-part interview with Generics Bulletin, he discusses the changes seen in the European off-patent industry over the last ten years, the way Medicines for Europe has evolved as an organization, and the